Amanda Mamie Reimer M.D.

Recommended Articles

• New Multiple Sclerosis Treatment, Ocrevus, Slows Down Disease Progression

  In 2017, the United States Food and Drug Administration (USFDA) approved the drug – Ocrevus (ocrelizumab) – as a treatment for both relapsing and progressive forms of multiple sclerosis. ...

• Researching Brain Changes in Multiple Sclerosis

  Due to the fact that MS can be difficult to diagnosis, there is currently no cure for the disease. Yet, researchers are continuously studying any changes within the brain in order to find ways to stop the progression of the disease.In a more recent study published in the medical journal of American...

• Migraines: What to Expect During Your Visit with a Neurologist

  What are migraines?Migraines are a condition that countless people live with, and often do not seek treatment for. They are severe headaches that come in episodes lasting around 2 to 72 hours. If you have migraines, you may also experience other symptoms such as vomiting, vision problems (seeing...

• What Is Lumosity?

  Introduction Lumosity is basically an online brain-training program, which consists of games to help in the improvement of flexibility, memory, attention span, the speed of processing information, quick problem-solving, and decision-making techniques. Lumos Labs was founded in the year 2005 by David...

• What Is Dysarthria: Symptoms, Causes, Treatment, and More

  What is dysarthria?Dysarthria is a speech disorder that is caused by weak, paralyzed, or damaged oral muscles. Those who have dysarthria usually have trouble speaking along with poor articulation, poor phonation, and poor respiration. Others may also have a hard time understanding people who have...

• The Fearless Model with Muscular Dystrophy Challenging Stereotypes

  It can’t be denied that people with disabilities (PWD) are often perceived as the object of pity. They are most of the time referred as dependent victims of the society. But it doesn’t stop a certain model named Jillian Mercado, who suffers from muscular dystrophy, in challenging many of those...